发明名称 |
OXIDOSQUALENE CYCLASE AS A PROTEIN TARGET FOR ANTICANCER THERAPEUTICS |
摘要 |
<p>The present invention identifies the cholesterol biosynthetic pathway, including the enzyme oxidosqualene cyclase, as new protein targets for anti-tumor therapeutics. The present invention further provides a class of oxidosqualene cyclase inhibitors containing a tertiary amine linked with aromatic ring structures, as a new class of anticancer agents. Compounds disclosed herein have been tested in 19 cell lines including breast cancer, prostate cancer, lung cancer (including drug-resistant lung cancer H69AR), colon cancer, ovarian cancer (including drug-resistant OVCAR-3), and pancreatic cancer cells, as wells as in human breast and prostate xenograft tumor growth in nude mice, and have been shown to be active.</p> |
申请公布号 |
EP2658544(A4) |
申请公布日期 |
2014.05.28 |
申请号 |
EP20110853116 |
申请日期 |
2011.12.22 |
申请人 |
THE CURATORS OF THE UNIVERSITY OF MISSOURI |
发明人 |
ZOU, XIAOQING;HYDER, SALMAN, M.;LIANG, YAYUN;GRINTER, SAM, Z;HUANG, SHENGYOU |
分类号 |
A61K31/5395;A61K31/357;A61K31/505;A61K31/54;A61K38/16;A61P35/00 |
主分类号 |
A61K31/5395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|